Christopher Simon - 29 Jun 2023 Form 4 Insider Report for HAEMONETICS CORP (HAE)

Role
President & CEO, Director
Signature
/s/ Thomas V. Powers, attorney-in-fact for Mr. Simon
Issuer symbol
HAE
Transactions as of
29 Jun 2023
Net transactions value
-$4,352,981
Form type
4
Filing time
30 Jun 2023, 16:17:03 UTC
Previous filing
19 May 2023
Next filing
13 Mar 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HAE Common Stock Options Exercise $5,629,887 +196,746 +91% $28.62 414,113 29 Jun 2023 Direct F1, F2
transaction HAE Common Stock Tax liability $9,982,868 -117,667 -28% $84.84 296,446 29 Jun 2023 Direct F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HAE Non-qualified Stock Option (Right to Buy) Options Exercise $0 -196,746 -100% $0.000000* 0 29 Jun 2023 Common Stock 196,746 $28.62 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents an automatic exercise of options granted in 2016 and scheduled to expire after June 29, 2023, as reflected in this Form 4.
F2 This number includes unvested restricted stock units previously reported.
F3 Represents shares withheld for tax obligations and for payment of the exercise price on exercised stock options reported in Table I.
F4 Option vests in annual increments of 25% beginning on the first anniversary of the date of grant.